Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Minamitake

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|July 8, 1998
Labelling peptides with fluorescent probes for incorporation into degradable polymersA Brunner, Y Minamitake, A Göpferich
The Journal of Toxicological Sciences|January 29, 1999
Effect of the spine venom from the crown-of-thorns starfish, Acanthaster planci, on drug-metabolizing enzyme in rat liverY Aniya, R Terukina, Y Minamitake, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1991
Characterization of ligand-binding properties and selectivities of three rat tachykinin receptors by transfection and functional expression of their cloned cDNAs in mammalian cellsT Ingi, Y Kitajima, Y Minamitake, et al.
Chemical & Pharmaceutical Bulletin|August 1, 1991
Structure-activity relationships of alpha-human atrial natriuretic peptide (alpha-hANP) analogs: role of charged groups in alpha-hANPY Minamitake, Y Kitajima, M Furuya, et al.
Biochemical and Biophysical Research Communications|November 15, 1990
Importance of hydrophobic residues in alpha-human atrial natriuretic peptide (alpha-hANP) for vasorelaxant activityY Minamitake, Y Kitajima, M Furuya, et al.
Chemical & Pharmaceutical Bulletin|July 1, 1990
Synthesis and biological property of alpha-human atrial natriuretic peptide analogs with a constrained or stereochemically modified cyclic moietyY Minamitake, M Furuya, Y Kitajima, et al.
Biochemical and Biophysical Research Communications|November 15, 1989
Linear alpha-human atrial natriuretic peptide analogs display receptor binding activity and inhibit alpha-hANP-induced cGMP accumulationY Kitajima, Y Minamitake, M Furuya, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1984
Human atrial natriuretic polypeptides (hANP): purification, structure synthesis and biological activityK Kangawa, A Fukuda, I Kubota, et al.
Journal of Biochemistry|February 1, 1990
Structure of recombinant human interleukin 5 produced by Chinese hamster ovary cellsY Minamitake, S Kodama, T Katayama, et al.
Science (New York, N.Y.)|March 18, 1994
Biodegradable long-circulating polymeric nanospheresR Gref, Y Minamitake, M T Peracchia, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|July 8, 1998
Labelling peptides with fluorescent probes for incorporation into degradable polymersA Brunner, Y Minamitake, A Göpferich
The Journal of Toxicological Sciences|January 29, 1999
Effect of the spine venom from the crown-of-thorns starfish, Acanthaster planci, on drug-metabolizing enzyme in rat liverY Aniya, R Terukina, Y Minamitake, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1991
Characterization of ligand-binding properties and selectivities of three rat tachykinin receptors by transfection and functional expression of their cloned cDNAs in mammalian cellsT Ingi, Y Kitajima, Y Minamitake, et al.
Chemical & Pharmaceutical Bulletin|August 1, 1991
Structure-activity relationships of alpha-human atrial natriuretic peptide (alpha-hANP) analogs: role of charged groups in alpha-hANPY Minamitake, Y Kitajima, M Furuya, et al.
Biochemical and Biophysical Research Communications|November 15, 1990
Importance of hydrophobic residues in alpha-human atrial natriuretic peptide (alpha-hANP) for vasorelaxant activityY Minamitake, Y Kitajima, M Furuya, et al.
Chemical & Pharmaceutical Bulletin|July 1, 1990
Synthesis and biological property of alpha-human atrial natriuretic peptide analogs with a constrained or stereochemically modified cyclic moietyY Minamitake, M Furuya, Y Kitajima, et al.
Biochemical and Biophysical Research Communications|November 15, 1989
Linear alpha-human atrial natriuretic peptide analogs display receptor binding activity and inhibit alpha-hANP-induced cGMP accumulationY Kitajima, Y Minamitake, M Furuya, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1984
Human atrial natriuretic polypeptides (hANP): purification, structure synthesis and biological activityK Kangawa, A Fukuda, I Kubota, et al.
Journal of Biochemistry|February 1, 1990
Structure of recombinant human interleukin 5 produced by Chinese hamster ovary cellsY Minamitake, S Kodama, T Katayama, et al.
Science (New York, N.Y.)|March 18, 1994
Biodegradable long-circulating polymeric nanospheresR Gref, Y Minamitake, M T Peracchia, et al.
Pageof 2